Drugs Made In America Acquisition II Corp. Company Profile
NASDAQ: DMIIFinanceBlank ChecksUSD
Market open · Delayed 15 min · as of Oct 9, 2:09 PM ET
Drugs Made In America Acquisition II at a glance
Drugs Made In America Acquisition II Corp. (NASDAQ: DMII) is a Blank Checks company in the Finance sector headquartered in New York, NY. Drugs Made In America Acquisition II is led by Mr. Roger Bendelac. The company's shares have traded publicly since 2025.
At a market capitalization of $649.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002040475, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Drugs Made In America Acquisition II do?
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Drugs Made In America Acquisition II Corp.
- Ticker
- NASDAQ: DMII
- Sector
- Finance
- Industry
- Blank Checks
- CEO
- Mr. Roger Bendelac
- Headquarters
- 420 Lexington Avenue, New York, NY, United States
- Phone
- 917 982 4565
- IPO year
- 2025
- Market cap
- $649.10M
- SEC CIK
- 0002040475
- Latest annual report
- 10-K · Apr 15, 2026
Companies similar to Drugs Made In America Acquisition II
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CCXIChurchill Capital Corp XI Class A | 10.99 | -0.47% | $612.03M | vs DMII |
| CEPFCantor Equity Partners IV Inc. Class A | 10.27 | 0.00% | $586.93M | vs DMII |
| CXIIChurchill Capital Corp XII Class A | 10.55 | -0.33% | $586.05M | vs DMII |
| XRPNArmada Acquisition Corp. II Class A | 17.20 | -28.93% | $543.35M | vs DMII |
| NWAXNew America Acquisition I Corp. Class A | 10.05 | +0.10% | $500.49M | vs DMII |
| MLAAMountain Lake Acquisition Corp. II Class A | 10.01 | 0.00% | $490.29M | vs DMII |
| BRTMB&R Technology Merger Corp. Class A | 9.80 | +0.10% | $479.18M | vs DMII |
| CRANCrane Harbor Acquisition Corp. II Class A | 10.10 | 0.00% | $473.69M | vs DMII |